Toxins in Drug Discovery and Pharmacology

Venoms from marine and terrestrial animals (cone snails, scorpions, spiders, snakes, centipedes, cnidarian, etc.) can be seen as untapped cocktails of biologically active compounds that are being increasingly recognized as a new emerging source of peptide-based therapeutics. Venomous animals are con...

Full description

Saved in:
Bibliographic Details
Main Author: Steve Peigneur (Ed.) (auth)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2018
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_61071
005 20210212
003 oapen
006 m o d
007 cr|mn|---annan
008 20210212s2018 xx |||||o ||| 0|eng d
020 |a 9783038428619 
020 |a 9783038428626 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a MMG  |2 bicssc 
100 1 |a Steve Peigneur (Ed.)  |4 auth 
245 1 0 |a Toxins in Drug Discovery and Pharmacology 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2018 
300 |a 1 electronic resource (XII, 304 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Venoms from marine and terrestrial animals (cone snails, scorpions, spiders, snakes, centipedes, cnidarian, etc.) can be seen as untapped cocktails of biologically active compounds that are being increasingly recognized as a new emerging source of peptide-based therapeutics. Venomous animals are considered to be specialized predators that have evolved the most sophisticated peptide chemistry and neuropharmacology for their own biological purposes by producing venoms that contain a structural and functional diversity of neurotoxins. These neurotoxins appear to be highly selective ligands for a wide range of ion channels and receptors. Therefore, they represent interesting lead compounds for the development of analgesics, anti-cancer drugs, drugs for neurological disorders such as multiple sclerosis, Parkinson' s disease, Alzheimer' s disease, and other therapeutics. This Special Issue of Toxins aims to provide a comprehensive look at toxins and toxin-inspired leads and will focus on the mechanisms of action, structure-function relationships, and evolution of pharmacologically interesting venom components, including the most recent developments related to the emergence of venoms as an underutilized source of highly evolved bioactive peptides with clinical potential. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Pharmacology  |2 bicssc 
653 |a calcium channels 
653 |a acetylcholine receptors 
653 |a peptides 
653 |a botulinum toxins 
653 |a TRP channels 
653 |a spider venom peptides 
653 |a sodium channels 
653 |a opiate receptors 
653 |a Antibiotics 
653 |a cone snail venom 
653 |a potassium channels 
653 |a chloride ion channels 
653 |a ASIC channels 
653 |a NMDA receptor 
653 |a antimicrobial peptides 
856 4 0 |a www.oapen.org  |u http://www.mdpi.com/books/pdfview/book/608  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/61071  |7 0  |z DOAB: description of the publication